Sign Up Today and Learn More About Zymergen Stock
Invest in or calculate the value of your shares in Zymergen or other pre-IPO companies through EquityZen's platform.
Zymergen Stock
Biotechnology Company
Zymergen researches, develops, and manufactures microbes for Fortune 500 companies. It develops molecules for agriculture, chemicals, materials, pharmaceuticals, electronics, personal care, and more applications. Zymergen’s platform integrates automation, machine learning, and genomics to navigate the genomic search space. It uses a technology platform to optimize strains that improve economics of in-market products, improve the existing production strains within existing manufacturing processes; and improve the correlation between the lab and commercial manufacturing. Moreover, Zymergen offers new product development, such as engineering any molecules from any microbes that improves the power of biology to develop novel products.
About Zymergen Stock
Founded
2013
Headquarters
Emeryville, CA, US
Total Funding
970M
Industries
Software, Artificial Intelligence, Data and Analytics
Zymergen researches, develops, and manufactures microbes for companies. It develops molecules for agriculture, chemicals, materials, pharmaceuticals, electronics, personal care, and more applications. Zymergen’s platform integrates automation, machine learning, and genomics to navigate the genomic search space. It uses a technology platform to optimize microbial strains that aims to improve economics of in-market products, existing production strains within existing manufacturing processes, and the correlation between the lab and commercial manufacturing. Moreover, Zymergen offers new product development, such as engineering any molecules from any microbes that improves the power of biology to develop novel products.
Jed Dean, Joshua J. Hoffman, and Zachary Serber founded the company in 2013, with headquarters in Emeryville in California and an additional office in Seattle in Washington.
Zymergen Press Mentions
Stay in the know about the latest news on Zymergen
Solving the World’s Problems With Biomanufacturing
nanalyze • Oct 01, 2020
Zymergen raised $300 million because synthetic biology is so hot right now
TechCrunch • Sep 09, 2020
Zymergen Takes Aim at $3 Trillion Chemical & Materials Industry With $300 Million in New Funding
finance • Sep 08, 2020
Zymergen Raises $300M in Funding
goo • Sep 08, 2020
Zymergen, FMC Form Crop Protection Technology Alliance
genomeweb • Aug 20, 2020
Investors in Zymergen
Discover investors in Zymergen stock and explore their portfolio companies
Zymergen Management
Leadership team at Zymergen
Chief Executive Officer
Joshua Hoffman
Chief Technology Officer
Aaron Kimball
Join now and verify your accreditation status to gain access to:
- Zymergen current valuation
- Zymergen stock price
- Available deals in Zymergen and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Zymergen Stock
How to invest in Zymergen stock?
Accredited investors can buy pre-IPO stock in companies like Zymergen through EquityZen funds. These investments are made available by existing Zymergen shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Zymergen stock?
Shareholders can sell their Zymergen stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
